Pet Health
Polycythemia Vera in Dogs: Symptoms, Diagnosis
The main problem is hyperviscosity syndrome, which occurs when excessive red blood cells make the blood too thick to circulate efficiently through small blood vessels.
Key takeaways
Polycythemia vera in dogs is a rare bone marrow disorder that causes excessive red blood cell production, making the blood abnormally thick and increasing the risk of serious complications.
- Polycythemia vera, also called primary erythrocytosis or canine polycythemia vera, occurs when the bone marrow produces too many red blood cells without the normal hormonal signals that regulate their production.
- The resulting increase in blood viscosity can interfere with circulation and oxygen delivery, potentially affecting the brain, eyes and other organs.
- Importantly, an elevated red blood cell count or hematocrit does not automatically mean a dog has polycythemia vera.
- Dehydration, heart disease, lung disease and kidney disorders can produce similar blood test results.
- Distinguishing between these conditions is essential because their treatments are different.
What Is Polycythemia Vera in Dogs?
Polycythemia vera is a rare myeloproliferative disorder in which blood-forming cells in the bone marrow multiply abnormally, resulting in excessive red blood cell production.
Unlike normal red blood cell production, this process becomes largely independent of erythropoietin (EPO), the hormone that ordinarily stimulates the bone marrow to make red blood cells.
Red blood cells carry oxygen throughout the body. When too many circulate in the bloodstream, blood becomes more viscous, or thicker. This can slow blood flow through small vessels and interfere with normal tissue perfusion. It can also increase the risk of blood clots and small-vessel bleeding.
Polycythemia vera is different from secondary polycythemia, in which another condition stimulates red blood cell production. It is also different from relative polycythemia, in which the blood appears concentrated because its fluid component has decreased rather than because the body has produced additional red blood cells.
Although the terms polycythemia and erythrocytosis are sometimes used interchangeably, erythrocytosis more specifically describes an increase in red blood cells. Polycythemia can also refer to increases in other blood cell types, including white blood cells and platelets.
Symptoms and Complications of Canine Polycythemia Vera
The main problem is hyperviscosity syndrome, which occurs when excessive red blood cells make the blood too thick to circulate efficiently through small blood vessels.
This can reduce tissue perfusion and increase the risk of blood clots and bleeding from small vessels.
Possible symptoms include:
• Red gums and other mucous membranes: The tissues inside the mouth may appear unusually red.
• Weakness and lethargy: Reduced circulation can interfere with normal tissue function.
• Neurological problems: These may include poor coordination, difficulty walking, seizures and changes in behavior.
• Vision problems: Severe cases can cause blindness.
• Bleeding tendencies: Abnormal bleeding may occur as blood viscosity increases.
• Excessive thirst and urination: Increased water consumption and production of urine can accompany the condition.
Not every affected dog displays all these signs. Some abnormalities may first be discovered during routine blood testing.
Why Thick Blood Is Dangerous
Excessive red blood cells increase resistance to blood flow. The resulting circulation problems can affect the brain, eyes and other organs. Blood flow through small vessels may become impaired, while the risk of thrombosis and small-vessel rupture increases.
Seizures, loss of coordination, sudden vision problems and unusual bleeding are particularly concerning because they can indicate significant complications.
What Causes Polycythemia Vera in Dogs?
The defining problem in primary erythrocytosis is uncontrolled red blood cell production by the bone marrow.
However, several other conditions can cause an elevated red blood cell concentration and must be investigated before diagnosing polycythemia vera.
Three main categories explain elevated red blood cell measurements.
1. Relative Polycythemia
Relative polycythemia occurs when the amount of fluid in the bloodstream decreases, making red blood cells appear more concentrated without an actual increase in total red blood cell mass.
Common causes include:
• Dehydration from vomiting or diarrhea.
• Significant fluid loss.
• Other conditions that reduce circulating plasma volume.
This type is treated by correcting dehydration and addressing the underlying problem. Blood measurements should improve when normal fluid balance is restored.
2. Secondary Absolute Polycythemia
Secondary erythrocytosis occurs when another condition stimulates the body to produce additional red blood cells.
It has two important forms.
Appropriate secondary erythrocytosis
This occurs when the body produces more erythropoietin because tissues are not receiving sufficient oxygen.
Possible underlying conditions include:
• Severe lung disease.
• Certain congenital heart defects.
• Heart abnormalities that allow blood to bypass the lungs, reducing oxygenation.
In these situations, additional red blood cells are a compensatory response intended to improve oxygen delivery.
Inappropriate secondary erythrocytosis
This occurs when red blood cell production increases without an underlying shortage of oxygen.
Possible causes include:
• Kidney tumors that produce erythropoietin.
• Tumors in other organs that produce erythropoietin.
• Kidney disorders that cause local tissue oxygen deprivation and stimulate erythropoietin production.
Treatment must address the underlying disease rather than assuming that excessive red blood cell production originates in the bone marrow.
3. Primary Polycythemia Vera
Primary erythrocytosis occurs when blood-forming cells multiply autonomously, producing excessive red blood cells without requiring the usual stimulation from erythropoietin.
Unlike relative polycythemia, this is a genuine increase in red blood cell mass. Unlike secondary polycythemia, it is not simply a response to heart disease, lung disease or excessive erythropoietin production.
How Is Polycythemia Vera Diagnosed in Dogs?
Diagnosing canine polycythemia vera requires more than identifying an elevated hematocrit.
The veterinarian must establish that the increase is persistent, determine whether it represents a genuine increase in red blood cell mass and investigate other possible causes.
1. Complete Blood Count
A complete blood count (CBC) measures several important blood components, including:
• Red blood cell count.
• Hemoglobin concentration.
• Hematocrit.
• White blood cell count.
• Platelet count.
The hematocrit, also called packed cell volume (PCV), represents the proportion of blood occupied by red blood cells.
An elevated hematocrit is an important indication of erythrocytosis, but it cannot independently distinguish primary disease from dehydration or secondary erythrocytosis.
2. Repeat Blood Testing and Hydration Assessment
Repeated blood testing helps determine whether an elevated hematocrit is persistent.
The veterinarian may assess:
• Hydration status.
• Total blood protein and albumin concentrations.
• Kidney-related blood measurements.
• Evidence of vomiting, diarrhea or other fluid losses.
• Changes in hematocrit following rehydration.
Dehydration can increase both hematocrit and blood protein concentrations. If the abnormality resolves after appropriate fluid replacement, relative erythrocytosis becomes more likely.
Greyhounds and other sighthounds also normally have higher red blood cell measurements than many other dog breeds, so breed-specific reference information matters when interpreting results.
3. Oxygenation and Heart and Lung Evaluation
If absolute erythrocytosis is suspected, the veterinarian may investigate whether the dog has inadequate oxygenation.
Depending on the clinical findings, testing may include:
• Pulse oximetry.
• Arterial blood gas analysis.
• Chest radiographs.
• Electrocardiography.
• Echocardiography.
• Heart and lung examinations.
These investigations help identify respiratory disease, cardiac abnormalities and conditions that cause insufficient oxygen delivery.
4. Kidney and Abdominal Imaging
If systemic oxygen deficiency does not explain the increased red blood cell production, the investigation may turn toward inappropriate erythropoietin production.
Abdominal ultrasound and other imaging methods can help identify kidney abnormalities, renal tumors or other potential sources of excessive erythropoietin production.
Blood chemistry and urine testing can provide additional information about kidney function and urinary abnormalities.
5. Erythropoietin Testing
Erythropoietin is the hormone that normally stimulates red blood cell production.
Dogs with primary erythrocytosis typically have low or low-normal erythropoietin activity, whereas secondary erythrocytosis may involve increased erythropoietin production.
However, erythropoietin measurements overlap between healthy animals and animals with primary or secondary erythrocytosis. Validated testing is also not widely available for companion animals. Consequently, an erythropoietin result alone cannot reliably establish the diagnosis.
6. Bone Marrow Examination
Bone marrow examination is not routinely useful for distinguishing primary from secondary erythrocytosis because both can produce increased red blood cell precursor activity in the marrow.
For this reason, polycythemia vera is generally diagnosed by excluding other explanations for persistent absolute erythrocytosis.
Treatment for Polycythemia Vera in Dogs
Treatment aims to reduce excessive red blood cell concentration, improve circulation and prevent complications associated with hyperviscosity.
The appropriate approach depends on whether the dog has primary polycythemia vera, secondary erythrocytosis or relative polycythemia.
1. Therapeutic Phlebotomy
Phlebotomy is the controlled removal of blood to reduce circulating red blood cell concentration.
It is an important initial treatment for primary polycythemia vera. Fluid replacement is provided at the same time to support circulating blood volume.
Because the underlying bone marrow abnormality can continue producing excessive red blood cells, periodic phlebotomy may be necessary.
The veterinarian determines when treatment is needed using the dog's clinical condition and repeat blood measurements.
2. Hydroxyurea
Hydroxyurea is a medication that suppresses excessive blood cell production in the bone marrow.
It may be used alongside periodic phlebotomy or as part of longer-term management of canine polycythemia vera. Its use in affected dogs is extra-label.
Hydroxyurea requires veterinary supervision and regular blood testing. Red blood cells, white blood cells and platelets must be monitored during treatment.
The treatment plan must be adjusted according to the dog's response and blood test results. It should not be started, stopped or adjusted without veterinary direction.
3. Treatment of Secondary Polycythemia
Secondary erythrocytosis requires a different approach.
For oxygen-related secondary erythrocytosis, treatment focuses on the underlying heart or lung disorder. If the underlying disease cannot be corrected, carefully selected treatments may help relieve hyperviscosity.
An important distinction is that blood removal must not reduce the red blood cell concentration to an inappropriate level. Because these additional cells are compensating for inadequate oxygenation, the hematocrit should remain above normal reference intervals.
For inappropriate secondary erythrocytosis, treatment focuses on the underlying kidney disease or erythropoietin-producing tumor. Depending on the cause, treatment may involve surgery, chemotherapy or radiation therapy. Phlebotomy may also be used to reduce excessive blood viscosity.
4. Treatment of Relative Polycythemia
If dehydration is responsible for the elevated hematocrit, treatment involves restoring fluid balance and addressing the cause of fluid loss.
Intravenous fluids may be required, particularly when dehydration is significant.
This is different from treating polycythemia vera because the problem is reduced plasma volume rather than uncontrolled bone marrow production.
Prognosis and Long-Term Management
The outlook for a dog with polycythemia vera depends on the severity of the condition, the presence of complications and the response to treatment.
The veterinary management approach involves controlling red blood cell concentration through periodic phlebotomy, hydroxyurea when indicated, or a combination of treatments.
Long-term management may involve:
• Repeat CBC testing.
• Monitoring hematocrit and hemoglobin.
• Monitoring white blood cell and platelet counts during hydroxyurea treatment.
• Assessing neurological function and other clinical signs.
• Adjusting treatment according to blood test results.
• Monitoring for signs of recurrent hyperviscosity.
There is no single survival estimate that applies to every affected dog. The ability to control excessive red blood cell production and prevent complications is central to ongoing management.
When Is Polycythemia Vera an Emergency?
A dog with severe erythrocytosis may develop complications involving the brain, eyes and circulation.
Seek emergency veterinary attention if a dog develops:
• A seizure.
• Sudden blindness or significant vision changes.
• Severe weakness.
• Loss of coordination or difficulty walking.
• Sudden behavioral or neurological changes.
• Unusual or significant bleeding.
These signs can indicate severe hyperviscosity and impaired blood flow. Increased blood viscosity is associated with an increased risk of thrombosis and rupture of small blood vessels.
Phlebotomy must be performed under veterinary supervision with appropriate fluid replacement. Hydroxyurea also requires blood-count monitoring, so neither treatment is appropriate to attempt independently.
Frequently asked questions
Is polycythemia vera in dogs a form of cancer?
Polycythemia vera is classified as a myeloproliferative disease involving abnormal, autonomous expansion of blood-forming cells. It primarily affects red blood cell production. It is different from secondary erythrocytosis, which develops because another condition stimulates red blood cell production.
Does a high hematocrit mean a dog has polycythemia vera?
No. An elevated hematocrit can result from dehydration, transient changes in circulating red blood cells, heart disease, lung disease, kidney disorders or primary polycythemia vera. Repeat blood testing and investigation of potential underlying causes are necessary before diagnosing primary disease.
Can dehydration cause polycythemia in dogs?
Yes. Dehydration reduces the liquid component of blood, making red blood cells appear more concentrated. This is called relative polycythemia. It is not the same as polycythemia vera because dehydration does not cause an actual increase in total red blood cell mass.
Can a dog with polycythemia vera have normal white blood cells and platelets?
Yes. Polycythemia vera primarily involves the red blood cell lineage, so increases in white blood cells and platelets are not necessary for the condition to be present. A CBC must be interpreted as a whole, rather than relying on one blood cell measurement.
Is hydroxyurea used to treat canine polycythemia vera?
Yes. Hydroxyurea is an extra-label treatment used to suppress excessive red blood cell production. It may be combined with periodic phlebotomy. Blood counts must be monitored during treatment to assess red blood cells, white blood cells and platelets.
Can polycythemia vera in dogs be cured?
The established veterinary management approach focuses on controlling excessive red blood cell production and reducing hyperviscosity. This may require repeated phlebotomy, hydroxyurea and ongoing blood testing. A treatment plan must be tailored to the individual dog rather than assuming that one procedure will permanently resolve the condition.
Is secondary polycythemia treated the same way as polycythemia vera?
No. Secondary polycythemia requires investigation and treatment of its underlying cause, such as heart disease, lung disease, kidney abnormalities or an erythropoietin-producing tumor. In oxygen-related secondary erythrocytosis, excessive blood removal can interfere with the body's compensatory response, so the hematocrit must be managed differently from primary polycythemia vera.
Editorial standards
Who wrote this guide
Written by VetWayfinder Editorial Team.
Every factual statement is tied to a cited source listed below. Report an error through the corrections page.
Sources
Each source supports at least one factual statement in this guide.
